Stock Taper
ZTS
ZOETIS INC.
NYSE
$77.34
▲ UP 3.09% (2.32)

KEY STATISTICS

Market Cap$32.42 B
52w High$155.38
52w Low$71.00
Dividend Yield2.69%
FrequencyQuarterly
P/E11.75
Volume4.84M
Shares Out.419.23M

COMPANY

LEADERSHIP

Kristin C. Peck
CHIEF EXECUTIVE
Kristin C. Peck

COMPENSATION 2026

Salary$1,300,000
Stock Awards$9,562,347
Incentive Plan Pay$2,730,000
All Other Comp.$426,913
Total$17,206,760

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 1, 2013
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
14,500

PRICE TARGET

Target High$95.00
Target Low$80.00
Target Median$85.00
Target Consensus$87.33

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$2.29B
NOV
3
TUE

PRICE

$77.34 ▲ UP 3.09% (+$2.32)
$75.75$76.50$77.259:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM77.34

About Zoetis Inc.

https://www.zoetis.com ↗

Zoetis develops and sells animal health medicines, vaccines, diagnostics, and related products for livestock and pets worldwide, serving veterinarians, producers, and distributors since 1952.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT ZOETIS INC. IS KNOWN FOR

Simparica Trio
Simparica Trio

A monthly chewable for dogs combines three active ingredients to protect against heartworm, ticks, fleas, roundworms, and hookworms, driving Zoetis' growth in the high-value companion animal market.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Dogs and Cats$1.59B $0 $1.44B $1.63B
Cattle$399M $415M $392M $390M
Swine$111M $125M $123M $117M
Poultry$106M $117M $118M $115M
Fish$78M $81M $66M $83M
Horses$66M $6.08B $76M $74M

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
United States Segment$1.32B $1.24B $1.09B $1.27B
International Segment$1.05B $1.12B $1.15B $1.17B

RATINGS SNAPSHOT

Overall rating: B+

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings2
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Purchase
2026-07-07
Gilbert Cisneros
Gilbert Cisneros
Purchase
2026-06-16
Byron Donalds
Byron Donalds
Purchase
2026-06-09
Charles J. "Chuck" Fleischmann
Charles J. "Chuck" Fleischmann
Purchase
2026-06-09

INSIDER TRADES

OFFICER: EVP, CFO & COO
SACCARO JAMES
· —
2026-08-17
DIRECTOR
DAMELIO FRANK A
Sale · 6.7K shares
2026-08-07
OFFICER: EXECUTIVE VICE PRESIDENT
Nayak Abhay U
Purchase · 214 shares
2026-07-10
OFFICER: EXECUTIVE VICE PRESIDENT
Esch Kevin
Purchase · 308 shares
2026-07-10

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
NEUTRAL 3
HOLD 2
OVERWEIGHT 2
OUTPERFORM 1
MARKET PERFORM 1
EQUAL WEIGHT 1
14 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
ELV$394.43COMPARE
REGN$794.19COMPARE
CI$278.88COMPARE
ARGX$1023.21COMPARE
COR$322.03COMPARE
TAK$18.03COMPARE
BDX$189.52COMPARE
HLN$10.11COMPARE